Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 14, 2014; 20(22): 7019-7026
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.7019
Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients
Marcin Włodarczyk, Aleksandra Sobolewska, Bartosz Wójcik, Karolina Loga, Jakub Fichna, Maria Wiśniewska-Jarosińska
Marcin Włodarczyk, Aleksandra Sobolewska, Bartosz Wójcik, Karolina Loga, Maria Wiśniewska-Jarosińska, Department of Gastroenterology, Medical University of Lodz, 90-647 Lodz, Poland
Jakub Fichna, Department of Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland
Author contributions: Włodarczyk M, Sobolewska A, Wójcik B, Loga K, Wiśniewska-Jarosińska M and Fichna J designed the research; Włodarczyk M, Sobolewska A, Wójcik B, Loga K and Wiśniewska-Jarosińska M performed the research; Włodarczyk M, Sobolewska A contributed new analytic tools; Włodarczyk M, Sobolewska A analyzed the data; Włodarczyk M, Sobolewska A, Wiśniewska-Jarosińska M and Fichna J wrote the paper; Włodarczyk M and Sobolewska A contributed equally to this study.
Supported by The student’s grant from the Foundation for Medical University of Lodz
Correspondence to: Maria Wiśniewska-Jarosińska, PhD, Department of Gastroenterology, Medical University of Lodz, Haller Sq. 1, 90-647 Lodz, Poland. maria.wisniewska-jarosinska@umed.lodz.pl
Telephone: +48-42-6393049  Fax: +48-42-6393049
Received: November 13, 2013
Revised: January 25, 2014
Accepted: March 6, 2014
Published online: June 14, 2014
Core Tip

Core tip: The important and often underestimated problem of skin lesions associated with biological treatment in Crohn’s disease. The authors found the correlation between the appearance of skin lesions and concentrations of interleukin (IL)-17A, IL-23 and interferon-γ in Crohn’s disease patients. This is a new and innovative view on the phenomenon “treat and trigger” in clinical practice. Better understanding the pathway of these disorders can influence the effectiveness of the treatment of skin lesions induced by biological therapy.